Inventor · disambiguated record
Marina Etinger
Also filed as: ETINGER MARINA · ETINGER MARINA Y · ETINGER MARINA YU
13 granted patents·10 pending applications·117 citations·filing 2001–2016
92Inventor score
Top patents by PatentIndex Score
23 records- 0191US7166730B2Process for the preparation of prostaglandin derivativesFINE TECH LAB LTD·Filed 2005·Granted Jan 23, 2007·26 cites·22 claims
- 0290US8383842B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolPURDUE PHARMA LP·Filed 2005·Granted Feb 26, 2013·13 cites·35 claims
- 0387US9744151B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2016·Granted Aug 29, 2017·6 cites·31 claims
- 0487US8937097B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolPURDUE PHARMA LP·Filed 2013·Granted Jan 20, 2015·7 cites·20 claims
- 0585US7157590B2Process for the preparation of 17-phenyl-18,19,20-thinor-pgf 2a and its derivativesFINETECH LAB LTD·Filed 2002·Granted Jan 2, 2007·19 cites·14 claims
- 0684US9278083B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2015·Granted Mar 8, 2016·4 cites·18 claims
- 0783US6849737B2Synthesis and purification of valacyclovirTEVA PHARMA·Filed 2002·Granted Feb 1, 2005·12 cites·24 claims
- 0880US6849736B2Crystalline forms of valacyclovir hydrochlorideTEVA PHARMA·Filed 2002·Granted Feb 1, 2005·11 cites·26 claims
- 0978US6927300B2Process for the preparation of LatanoprostFINETECH LAB LTD·Filed 2001·Granted Aug 9, 2005·12 cites·15 claims
- 1067US7692023B2Candesartan cilexetil polymorphsTEVA PHARMA·Filed 2005·Granted Apr 6, 2010·1 cites·5 claims
- 1167US7098342B2Preparation of candesartan cilexetilTEVA PHARMA·Filed 2004·Granted Aug 29, 2006·3 cites·24 claims
- 1265US7262327B2Recycling process for preparing sertralineTEVA PHARMA·Filed 2004·Granted Aug 28, 2007·3 cites·50 claims
- 1358US9675581B2Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinolSVC PHARMA LP·Filed 2016·Granted Jun 13, 2017·0 cites·24 claims
- 1453US2006252939A1Preparation of candesartan cilexetilETINGER MARINA Y·Filed 2006·Application pending·0 cites
- 1551US2005130993A1Synthesis and purification of valacyclovirFiled 2005·Application pending·0 cites
- 1648US2005187229A1Crystalline forms of valacyclovir hydrochlorideFiled 2005·Application pending·0 cites
- 1745US2009192326A1Preparation of sitagliptin intermediatePERLMAN NURIT·Filed 2008·Application pending·0 cites
- 1844US2005250827A1Preparation of candesartan cilexetil in high purityETINGER MARINA Y·Filed 2004·Application pending·0 cites
- 1942US2005043329A1Crystalline forms of valacyclovir hydrochlorideFiled 2004·Application pending·0 cites
- 2040US2005239837A1Process for production of highly pure donepezil hydrochlorideGUTMAN ARIE L·Filed 2005·Application pending·0 cites
- 2139US2010121072A1Candesartan cilexetil polymorphsETINGER MARINA YU·Filed 2010·Application pending·0 cites
- 2239US2005215600A1Polymorphs of torsemide hydrochloride and process for production thereofGUTMAN ARIE·Filed 2004·Application pending·0 cites
- 2335US2012220663A1Solid forms of aliskiren hemifumarate and processes for preparation thereofETINGER MARINA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →